fig1

Multimodal 4-arylchromene derivatives with microtubule-destabilizing, anti-angiogenic, and MYB-inhibitory activities

Figure 1. Structures of LY290181 (1A); MYB inhibitor Bcr-TMP (1B); chromosomal de-clustering agent 1C; and antiproliferative compound 2B.

Cancer Drug Resistance
ISSN 2578-532X (Online)

Portico

All published articles will preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles will preserved here permanently:

https://www.portico.org/publishers/oae/